David J. Gury
Direktor/Vorstandsmitglied bei Scripps Florida Funding Corp.
Profil
David J.
Gury is currently the Vice Chairman at Scripps Florida Funding Corp.
and Treasurer at Florida Atlantic University Foundation, Inc. He is also the Principal at Gury Consulting LLC.
Previously, he served as Chairman, President & CEO at Nabi Biopharmaceuticals from 1984 to 2004.
He was also the Chairman at Oragenics, Inc. from 2003 to 2008 and Director at U.S.
Stem Cell, Inc. from 2005 to 2009.
He has also served as Chairman at BioFlorida, Inc. Mr. Gury holds an MBA from The University of Chicago and an undergraduate degree from Kenyon College.
Aktive Positionen von David J. Gury
| Unternehmen | Position | Beginn |
|---|---|---|
| Gury Consulting LLC | Corporate Officer/Principal | 01.06.2004 |
| Scripps Florida Funding Corp. | Direktor/Vorstandsmitglied | 01.04.2005 |
| Florida Atlantic University Foundation, Inc. | Treasurer | - |
Ehemalige bekannte Positionen von David J. Gury
| Unternehmen | Position | Ende |
|---|---|---|
| U.S. STEM CELL, INC. | Direktor/Vorstandsmitglied | 07.01.2009 |
| ORAGENICS, INC. | Vorsitzender | 08.04.2008 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Vorsitzender | 01.05.2004 |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Vorsitzender | - |
Ausbildung von David J. Gury
| The University of Chicago | Masters Business Admin |
| Kenyon College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ORAGENICS, INC. | Health Technology |
| U.S. STEM CELL, INC. | Health Services |
| Private Unternehmen | 5 |
|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |
| Scripps Florida Funding Corp. | |
| Florida Atlantic University Foundation, Inc. | |
| Gury Consulting LLC |